Acquisitions21 Feb 2025, 03:27 am
Sanofi and Clayton Dubilier & Rice Announce Exclusive Negotiations for Acquisition of Opella Healthcare SAS
AI Summary
Sanofi and Clayton Dubilier & Rice, LLC, the manager of the Clayton Dubilier & Rice private equity funds, have entered into exclusive negotiations for the acquisition of a controlling stake in Opella Healthcare SAS by the CD&R Group. The CD&R Group has made a mandatory open offer for the transaction, which is subject to receiving the required statutory approvals before 21 October 2025. Upon completion, the CD&R Group and the Sanofi group would jointly hold 60.40% of the voting rights of Sanofi Consumer Healthcare India Limited, with the CD&R Group having control over the exercise of these voting rights.
Key Highlights
- Sanofi and Clayton Dubilier & Rice, LLC have entered into exclusive negotiations for the acquisition of Opella Healthcare SAS by the CD&R Group.
- The CD&R Group has made a mandatory open offer for the transaction.
- The transaction is subject to receiving the required statutory approvals before 21 October 2025.
- Upon completion, the CD&R Group and the Sanofi group would jointly hold 60.40% of the voting rights of Sanofi Consumer Healthcare India Limited.
- The CD&R Group would have control over the exercise of these voting rights.